HIV/AIDS cases decline in Malawi; testing, counseling sites increase, health official says

HIV prevalence among people ages 15 to 49 in Malawi declined to 12% in 2007, and there are now 410 sites offering HIV testing and counseling, National AIDS Commission Board Chair Nicholas Chitimba said recently, Malawi's National News reports.

According to the News, HIV prevalence had been as high as 14% in previous years.

Speaking at a ceremony to distribute motorcycles, bicycles and computers to three government ministries and HIV/AIDS service providers, Chitimba said that as of March, 146,000 people in the country had started antiretroviral treatment. He also said that the country has 425 sites that offer services to pregnant women and their spouses to prevent mother-to-child HIV transmission.

The Ministry of Health and other partners plan to launch a two-week National HIV testing and counseling campaign in August. According to Chitimba, seven million Malawians are sexually active, and about 2.8 million people have undergone HIV testing and counseling. "If you were negative last year, it does not mean you should not get tested again," Chitimba said (Khunga, National News, 5/2).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug